Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zimy Wansaula"'
Autor:
Zimy Wansaula, Jonathan M. Wortham, Godwin Mindra, Maryam B. Haddad, Jorge L. Salinas, David Ashkin, Sapna B. Morris, Gail B. Grant, Smita Ghosh, Adam J. Langer
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 451-456 (2019)
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surv
Externí odkaz:
https://doaj.org/article/f424a8f4b5154a09a4cbf7beb129b884
Autor:
Steve R. Barnes, Zimy Wansaula, Kristen Herrick, Eyal Oren, Kacey Ernst, Sonja J. Olsen, Mariana G. Casal
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background From October 2010 through February 2016, Arizona conducted surveillance for severe acute respiratory infections (SARI) among adults hospitalized in the Arizona-Mexico border region. There are few accurate mortality estimates in SA
Externí odkaz:
https://doaj.org/article/400ec49adcb946699543db75a2b2e6f1
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 66:289-294
In 2016, a total of 9,287 new tuberculosis (TB) cases were reported in the United States; this provisional* count represents the lowest number of U.S. TB cases on record and a 2.7% decrease from 2015 (1). The 2016 TB incidence of 2.9 cases per 100,00
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4257de6569c854088858bf257d14327e
https://doi.org/10.15585/mmwr.mm6611a2
https://doi.org/10.15585/mmwr.mm6611a2
Autor:
Sapna Bamrah Morris, Gail Grant, Smita Ghosh, Jonathan M. Wortham, Jorge L. Salinas, Maryam B. Haddad, David Ashkin, Zimy Wansaula, Adam J. Langer, Godwin Mindra
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 451-456 (2019)
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 451-456 (2019)
TOC summary: Clinical history can discern probable BCG cases from TB cases, enabling optimal clinical management.
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe0a47107930767eefc0e34d58d5690
https://pubmed.ncbi.nlm.nih.gov/30789145
https://pubmed.ncbi.nlm.nih.gov/30789145
Autor:
Natalie N. Whitfield, Laura M. Erhart, Peter E. Kammerer, Zimy Wansaula, Catherine Golenko, Mariana Casal, Orion McCotter, Sonja J. Olsen
Publikováno v:
Influenza and Other Respiratory Viruses
Background The Binational Border Infectious Disease Surveillance program began surveillance for severe acute respiratory infections (SARI) on the US–Mexico border in 2009. Here, we describe patients in Southern Arizona. Methods Patients admitted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363a5812d82a45654cca06a3f2580362
https://doi.org/10.1111/irv.12360
https://doi.org/10.1111/irv.12360
Autor:
Steve R. Barnes, Mariana Casal, Zimy Wansaula, Kacey C. Ernst, Kristen Herrick, Eyal Oren, Sonja J. Olsen
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
Background From October 2010 through February 2016, Arizona conducted surveillance for severe acute respiratory infections (SARI) among adults hospitalized in the Arizona-Mexico border region. There are few accurate mortality estimates in SARI patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::921f505d7e6105ac846b6016218344c3
https://pubmed.ncbi.nlm.nih.gov/29433471
https://pubmed.ncbi.nlm.nih.gov/29433471